[Hemosorption in the complex treatment of arteriosclerotic dyscirculatory encephalopathy associated with chronic ischemic heart disease].
Hemosorption was included in combined treatment of 110 patients with atherosclerotic dyscirculatory encephalopathy combined with coronary heart disease. The effect was assessed on the basis of clinical improvement, psychological tests, blood lipid assays, compressed spectral EEG analysis and ultrasonic flowmetry of the carotid arteries. The effectiveness of hemosorption was demonstrated at all stages of the disease, with the regression of general cerebral and focal neurologic symptoms preceding clinical remission of coronary heart disease. Hemosorption was shown to have good effects on blood lipids, cerebral circulation and EEG spectrograms.
D000328:Adult; D000368:Aged; D002545:Brain Ischemia / Q000209:etiology / Q000628:therapy*; D002606:Charcoal; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000150:complications*; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications*; D008297:Male; D008875:Middle Aged
C029814:SKN hemosorbents; D002606:Charcoal
Gemosorbtsiia v kompleknsom lechenii ateroskleroticheskoĭ distsirkuliatornoĭ éntsefalopatii, sochetaiushcheĭsia s khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa.